Did targeted therapy fail cyclooxygenase too?

被引：11

作者：

Csiki, Ildiko ^{[1
]}

Johnson, David H. ^{[1
]}

机构：

[1] Vanderbilt Ingram Canc Ctr, Div Hematol & Oncol, Nashville, TN USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 30期

关键词：

D O I：

10.1200/JCO.2006.08.0622

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

引用

页码：4798 / 4800

页数：3

共 23 条

[1]

Celecoxib, a selective cyclo-oxygenase-2 inhibitor, enhances the response to preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer [J].

Altorki, NK ;

Keresztes, RS ;

Port, JL ;

Libby, MD ;

Korst, RJ ;

Flieder, DB ;

Ferrara, CA ;

Yankelevitz, DF ;

Subbaramaiah, K ;

Pasmantier, MW ;

Dannenberg, AJ .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (14) :2645-2650

[2]

Cyclooxygenase as a target in lung cancer [J].

Brown, JR ;

DuBois, RN .

CLINICAL CANCER RESEARCH, 2004, 10 (12) :4266S-4269S

[3]

Targeting cyclooxygenase-2 in recurrent non-small cell lung cancer: A phase II trial of celecoxib and docetaxel [J].

Csiki, I ;

Morrow, JD ;

Sandler, A ;

Shyr, Y ;

Oates, J ;

Williams, MK ;

Dang, T ;

Carbone, DP ;

Johnson, DH .

CLINICAL CANCER RESEARCH, 2005, 11 (18) :6634-6640

[4]

NAD+-linked 15-hydroxyprostaglandin dehydrogenase (15-PGDH) behaves as a tumor suppressor in lung cancer [J].

Ding, YF ;

Tong, M ;

Liu, SQ ;

Moscow, JA ;

Tai, HH .

CARCINOGENESIS, 2005, 26 (01) :65-72

[5]

Edelman MJ, 2006, J CLIN ONCOL, V24, p370S

[6]

Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors [J].

Groesch, Sabine ;

Maier, Thorsten Juergen ;

Schiffmann, Susanne ;

Geisslinger, Gerd .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2006, 98 (11) :736-747

[7]

Levels of prostaglandin E metabolite, the major urinary metabolite of prostaglandin E2, are increased in smokers [J].

Gross, ND ;

Boyle, JO ;

Morrow, JD ;

Williams, MK ;

Moskowitz, CS ;

Subbaramaiah, K ;

Dannenberg, AJ ;

Duffield-Lillico, AJ .

CLINICAL CANCER RESEARCH, 2005, 11 (16) :6087-6093

[8]

Hida T, 2000, CLIN CANCER RES, V6, P2006

[9]

PROSTACYCLIN - A POTENT ANTI-METASTATIC AGENT [J].

HONN, KV ;

CICONE, B ;

SKOFF, A .

SCIENCE, 1981, 212 (4500) :1270-1272

[10]

Krysan Kostyantyn, 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P209, DOI 10.2174/187152006776930882

← 1 2 3 →